Bogle Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bogle Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,431	Closed	-$810K	–	292
2020 Q3	$810K	Sell	10,431 -30,773	-75%	-$2.12M	0.24%	118
2020 Q2	$2.29M	Sell	41,204 -308,404	-88%	-$13.2M	0.38%	123
2020 Q1	$10.4M	Sell	349,608 -65,361	-16%	-$2.21M	1.08%	26
2019 Q4	$15M	Sell	414,969 -95,063	-19%	-$2.91M	1.4%	1
2019 Q3	$13.9M	Buy	510,032 +18,045	+4%	+$467K	1.2%	10
2019 Q2	$11.8M	Buy	491,987 +32,744	+7%	+$831K	0.93%	40
2019 Q1	$12.1M	Buy	459,243 +401,073	+689%	+$9.5M	0.93%	48
2018 Q4	$1.14M	Sell	58,170 -360,009	-86%	-$7.06M	0.09%	204
2018 Q3	$8.19M	Sell	418,179 -220,564	-35%	-$4.19M	0.59%	71
2018 Q2	$10.6M	Buy	+638,743	New	+$9.74M	0.76%	65

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bogle Investment Management's HZNP Position: Q4 2020 in Review

Bogle Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2020, closing a stake of 10,431 shares — an estimated $810K sold.

Bogle Investment Management first reported a position in HZNP in Q2 2018 and held it in 10 quarters. The position peaked at $15M in Q4 2019. 497 funds tracked by Wall St. Rank hold HZNP as of Q4 2020.

Bogle Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2020 after selling out during the quarter.
Bogle Investment Management sold 10,431 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2020, an estimated $810K.
Bogle Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and held it in 10 quarters.
Bogle Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15M in Q4 2019.
497 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.